Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. Chari A, Minnema MC, Berdeja JG, Oriol A, et al. N Engl J Med 2022;387:2232-2244.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chari A, Minnema MC, Berdeja JG, Oriol A, et al. Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma. N Engl J Med 2022;387:2232-2244.
PMID: 36507686